- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03082794
Dietary Effects on Weight Loss and Lipid Profile in Sedentary Men
March 17, 2017 updated by: Mohammadreza Rezaeipour, MD, PhD, P.L.Shupik National Medical Academy of Post-Graduate Education
Investigating the Effects of Negative Calorie Diet Compared With Low-Calorie Diet on Weigh Loss and Lipid Profile in Sedentary Overweight/Obese Middle-Aged and Older Men
Negative-calorie diet is among the popular dieting guides for weight loss; however, there is still little knowledge about this method.
The present study aimed to determine the effects of negative-calorie diet on weight loss and lipid profile, and to compare its efficiency with low-calorie diet in men.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Non-smokers
- Weight-stable (± 2 kg, for more than one year)
- No history of regular exercise (in at least three months before the study).
Exclusion Criteria:
- History of medical disorders (CVD and other such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals, abnormality in thyroid or Electrocardiograph
- History of anti-obesity medication or weight loss drugs or dietary supplementations for weight control.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study group I
Study group I (53 participants) received the NCD (details of diet: 15% protein, 75% carbohydrates, 10% fat).
Both groups had 15% caloric restriction from their maintenance energy requirements.
|
Negative Calorie Diet
Other Names:
|
|
Experimental: Study group II
Study group II (51 participants) received the LCD or healthy weight maintenance diet (details of diet: 15% protein, 55% carbohydrates, 30% fat).Both groups had 15% caloric restriction from their maintenance energy requirements.
|
Low Calorie Diet
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Baseline
|
assessed in kg
|
Baseline
|
|
Total cholesterol (Total-C)
Time Frame: Baseline
|
assessed in mg/dl
|
Baseline
|
|
High-density lipoprotein -cholesterol (HDL-C)
Time Frame: Baseline
|
assessed in mg/dl
|
Baseline
|
|
Low-density lipoprotein -cholesterol (LDL-C)
Time Frame: Baseline
|
assessed in mg/dl
|
Baseline
|
|
Triglycerides (TG)
Time Frame: Baseline
|
assessed in mg/dl
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 3-month
|
assessed in kg
|
3-month
|
|
Total cholesterol (Total-C)
Time Frame: 3-month
|
assessed in mg/dl
|
3-month
|
|
High-density lipoprotein -cholesterol (HDL-C)
Time Frame: 3-month
|
assessed in mg/dl
|
3-month
|
|
Low-density lipoprotein -cholesterol (LDL-C)
Time Frame: 3-month
|
assessed in mg/dl
|
3-month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 20, 2011
Primary Completion (Actual)
September 20, 2012
Study Completion (Actual)
December 27, 2012
Study Registration Dates
First Submitted
March 4, 2017
First Submitted That Met QC Criteria
March 12, 2017
First Posted (Actual)
March 17, 2017
Study Record Updates
Last Update Posted (Actual)
March 21, 2017
Last Update Submitted That Met QC Criteria
March 17, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- no Grant 4
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on NCD
-
University of Illinois at Urbana-ChampaignAmericares; Royal Health Awareness SocietyCompletedHypertension | Diabetes | Mental StressJordan
-
P.L.Shupik National Medical Academy of Post-Graduate...CompletedObesity | Overweight | Life Style
-
Icahn School of Medicine at Mount SinaiKathmandu University School of Medical SciencesNot yet recruitingHypertension | DiabetesNepal
-
Johns Hopkins Bloomberg School of Public HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHypertension | Tobacco Smoking | Type 2 Diabetes Mellitus (T2DM)Nepal
-
Aga Khan UniversityRoyal Society of Tropical Medicine and Hygiene (RSTMH) funded by NIHRNot yet recruitingCardiovascular Diseases | Lung Diseases | Diabetes Mellitus | Cancer
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Antiretroviral Therapy, Highly ActiveSouth Africa
-
PossibleNyaya Health Nepal; Ministry of Health and Population, NepalWithdrawnHypertension | Diabetes Mellitus, Type 2 | Chronic Obstructive Pulmonary Disease | Noncommunicable DiseasesNepal
-
BRAC UniversityActive, not recruitingHypertension | Diabetes | Asthma | Chronic Obstructive Pulmonary Disease (COPD)Bangladesh
-
CASI pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
Aga Khan UniversityFogarty International Center of the National Institutes of HealthRecruitingHealth Knowledge, Attitudes, Practice | Noncommunicable Diseases | Non-communicable Disease Risk FactorsPakistan